Home Casteddu.com FAQ My Amedeo About Flying Publisher   

The Medical Article of the Year 2008:
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78.
Free full-text


  Leukemia

 

Free Subscription


09.07.2008

1 Am J Clin Pathol
3 Ann Hematol
5 Blood
6 Br J Haematol
1 Cancer
1 Cancer Res
1 Exp Hematol
2 Int J Hematol
3 J Clin Oncol
4 Leukemia
1 Virology


   Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Pathol

  1. BURESH CJ , Oliai BR, Miller RT
    Reactivity with TdT in Merkel cell carcinoma: a potential diagnostic pitfall.
    Am J Clin Pathol. 2008;129:894-8.
    PubMed     Related articles    Abstract available


    Ann Hematol

  2. ORTMANN CA , Eisele L, Nuckel H, Klein-Hitpass L, et al
    Aberrant hypomethylation of the cancer-testis antigen PRAME correlates with PRAME expression in acute myeloid leukemia.
    Ann Hematol. 2008;.
    PubMed     Related articles    Abstract available

  3. LAURENTI L , Tarnani M, De Padua L, Efremov DG, et al
    Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration.
    Ann Hematol. 2008;.
    PubMed     Related articles    Abstract available

  4. CARNICER MJ , Lasa A, Buschbeck M, Serrano E, et al
    K313dup is a recurrent CEBPA mutation in de novo acute myeloid leukemia (AML).
    Ann Hematol. 2008;.
    PubMed     Related articles    Abstract available


    Blood

  5. PEPPER C , Lin TT, Pratt G, Hewamana S, et al
    Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers.
    Blood. 2008;.
    PubMed     Related articles    Abstract available

  6. MATSUSHITA K , Margulies I, Onda M, Nagata S, et al
    Soluble CD22 as a tumor marker for hairy cell leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available

  7. QUINTARELLI C , Dotti G, De Angelis B, Hoyos V, et al
    Cytotoxic T lymphocytes directed to the Preferentially Expressed Antigen of Melanoma (PRAME) target chronic myeloid leukemia.
    Blood. 2008;.
    PubMed     Related articles    Abstract available

  8. RAO R , Fiskus W, Yang Y, Lee P, et al
    HDAC6 inhibition enhances 17-AAG-mediated abrogation of hsp90 chaperone function in human leukemia cells.
    Blood. 2008;.
    PubMed     Related articles    Abstract available

  9. CHEN CI , Maecker HT, Lee PP
    Development and dynamics of robust T-cell responses to CML under imatinib treatment.
    Blood. 2008;111:5342-9.
    PubMed     Related articles    Abstract available


    Br J Haematol

  10. AL SHAER L , Walsby E, Gilkes A, Tonks A, et al
    Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signalling.
    Br J Haematol. 2008;141:483-93.
    PubMed     Related articles    Abstract available

  11. KELLY RJ , Wright D, Patil K, Chapple M, et al
    t(14;19)(q32;q13) incidence and significance in B-cell lymphoproliferative disorders.
    Br J Haematol. 2008;141:561-3.
    PubMed     Related articles   

  12. MEAD AJ , Gale RE, Kottaridis PD, Matsuda S, et al
    Acute myeloid leukaemia blast cells with a tyrosine kinase domain mutation of FLT3 are less sensitive to lestaurtinib than those with a FLT3 internal tandem duplication.
    Br J Haematol. 2008;141:454-60.
    PubMed     Related articles    Abstract available

  13. NAHI H , Selivanova G, Lehmann S, Mollgard L, et al
    Mutated and non-mutated TP53 as targets in the treatment of leukaemia.
    Br J Haematol. 2008;141:445-53.
    PubMed     Related articles    Abstract available

  14. KELLY K , Murphy K, Farrell M, Rawluk D, et al
    Intracranial small lymphocytic lymphoma.
    Br J Haematol. 2008;.
    PubMed     Related articles   

  15. CAPELLO D , Deambrogi C, Rossi D, Lischetti T, et al
    Epigenetic inactivation of suppressors of cytokine signalling in Philadelphia-negative chronic myeloproliferative disorders.
    Br J Haematol. 2008;141:504-11.
    PubMed     Related articles    Abstract available


    Cancer

  16. HUANG J , Li CY, Mesa RA, Wu W, et al
    Risk factors for leukemic transformation in patients with primary myelofibrosis.
    Cancer. 2008;112:2726-32.
    PubMed     Related articles    Abstract available


    Cancer Res

  17. SAMUDIO I , Fiegl M, McQueen T, Clise-Dwyer K, et al
    The warburg effect in leukemia-stroma cocultures is mediated by mitochondrial uncoupling associated with uncoupling protein 2 activation.
    Cancer Res. 2008;68:5198-205.
    PubMed     Related articles    Abstract available


    Exp Hematol

  18. DIDA F , Li Y, Iwao A, Deguchi T, et al
    Resistance to TRAIL-induced apoptosis caused by constitutional phosphorylation of Akt and PTEN in acute lymphoblastic leukemia cells.
    Exp Hematol. 2008;.
    PubMed     Related articles    Abstract available


    Int J Hematol

  19. HUANG KP , Chase AJ, Cross NC, Reiter A, et al
    Evolutional change of karyotype with t(8;9)(p22;p24) and HLA-DR immunophenotype in relapsed acute myeloid leukemia.
    Int J Hematol. 2008;.
    PubMed     Related articles    Abstract available

  20. SHIGEKIYO T , Miyagi J, Chohraku M, Kawauchi K, et al
    Bleeding tendency in chronic neutrophilic leukemia.
    Int J Hematol. 2008;.
    PubMed     Related articles   


    J Clin Oncol

  21. KESARI S , Drappatz J, Akar S, Vergilio JA, et al
    Recurrent acute promyelocytic leukemia presenting as a sacral nerve root mass.
    J Clin Oncol. 2008;26:3279-81.
    PubMed     Related articles   

  22. VIRAPPANE P , Gale R, Hills R, Kakkas I, et al
    Mutation of the Wilms' Tumor 1 Gene Is a Poor Prognostic Factor Associated With Chemotherapy Resistance in Normal Karyotype Acute Myeloid Leukemia: The United Kingdom Medical Research Council Adult Leukaemia Working Party.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available

  23. BAER MR , George SL, Caligiuri MA, Sanford BL, et al
    Low-Dose Interleukin-2 Immunotherapy Does Not Improve Outcome of Patients Age 60 Years and Older With Acute Myeloid Leukemia in First Complete Remission: Cancer and Leukemia Group B Study 9720.
    J Clin Oncol. 2008;.
    PubMed     Related articles    Abstract available


    Leukemia

  24. SHIMONI A , Leiba M, Schleuning M, Martineau G, et al
    Prior treatment with the tyrosine kinase inhibitors dasatinib and nilotinib allows stem cell transplantation (SCT) in a less advanced disease phase and does not increase SCT Toxicity in patients with chronic myelogenous leukemia and philadelphia positive
    Leukemia. 2008;.
    PubMed     Related articles   

  25. BOWEN D , Groves MJ, Burnett AK, Patel Y, et al
    TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis.
    Leukemia. 2008;.
    PubMed     Related articles   

  26. PEREZ-GALAN P , Roue G, Lopez-Guerra M, Nguyen M, et al
    BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells.
    Leukemia. 2008;.
    PubMed     Related articles    Abstract available

  27. CARDOSO BA , Martins LR, Santos CI, Nadler LM, et al
    Interleukin-4 stimulates proliferation and growth of T-cell acute lymphoblastic leukemia cells by activating mTOR signaling.
    Leukemia. 2008;.
    PubMed     Related articles   


    Virology

  28. DIAZ-GRIFFERO F , Perron M, McGee-Estrada K, Hanna R, et al
    A human TRIM5alpha B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus.
    Virology. 2008;.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: